Design
Review
Authors
Loading...
NOS isoform specificity may enable targeted NO modulation in CV disease; leaves open prospective validation.
Key points are not available for this paper at this time.
Carl Nathan (1992) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: